Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients
MicroRNAs (miRNAs) dysregulation has been shown to play a critical regulatory role in papillary thyroid carcinomas (PTCs). BRAF mutation is associated with poor clinicopathological outcomes in PTC. In order to identify a possible association between dysregulated miRNA expression and BRAF mutation as...
Main Authors: | Yun Sun, Shuang Yu, Yuanyuan Liu, Fen Wang, Yujie Liu, Haipeng Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2013/128735 |
Similar Items
-
The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients
by: Li-Bo Yang, et al.
Published: (2015-01-01) -
Identification of key genes and miRNAs markers of papillary thyroid cancer
by: Jie Qiu, et al.
Published: (2018-11-01) -
Aberrant expression of five miRNAs in papillary thyroid carcinomas
by: Cheng, L., et al.
Published: (2021) -
Prevalence of BRAF Mutation in Papillary Thyroid Cancer
by: Shatha Dmour, et al.
Published: (2016-12-01) -
BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features
by: Chenlei Shi, et al.
Published: (2020-06-01)